Analyst Ratings For CVS Health Within the last quarter, CVS Health (NYSE:CVS) has observed the following analyst ratings: Benzinga · Feb 14, 2022
Is Now The Time To Buy Stock In DiDi Global, Affirm, Zoom Or CVS Health? One of the most common questions traders have about stocks is “Why Is It Moving?” Benzinga · Feb 14, 2022
$100 Invested In This Stock 20 Years Ago, Would Be Worth This Much CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 3.35% on an annualized basis. Benzinga · Feb 10, 2022
CVS Health Earnings Perspective: Return On Invested Capital According to Benzinga Pro data CVS Health (NYSE:CVS) posted a 18.34% decrease in earnings from Q3. Sales, however, increased by 3.81% over the previous quarter to $76.60 billion. Benzinga · Feb 10, 2022
CVS Health: Q4 Earnings Insights CVS Health (NYSE:CVS) reported its Q4 earnings results on Wednesday, February 9, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Benzinga · Feb 9, 2022
CVS Health Fourth Quarter Performance Gets A Boost From COVID-19 Vaccinations, Reaffirms FY22 Outlook CVS Health Corporation's (NYSE: CVS) Benzinga · Feb 9, 2022
What Are Whales Doing With CVS Health Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Benzinga · Jan 27, 2022
Karen Lynch got the big job at CVS. Now comes the big challenge: Vaccinate America The new CVS Health chief is the highest-ranking female CEO ever to appear in the Fortune 500—just in time for the company’s most important mission yet. Fortune · Mar 15, 2021